// App-Quantinova.ai

606 : The Contribution of Posttransplant RBC Transfusions and Missing Dose of Methotrexate Prophylaxis to the Development of Acute Graft Versus Host Disease in Children

Researchers

Presenter

  • Ulker Kocak

Principal Investigators

  • Zuhre Kaya

  • Ebru Yilmaz Keskin

  • Fatma Burcu Belen

  • Nergiz Oner

  • Melek Isik

  • Ahmet Ertan Sal

  • Funda Tekkesin

  • Ilhan Altan

  • Idil Yenicesu

  • Turkiz Gursel

Medical Centers

  • Pediatric Bone Marrow Transplantation Unit, Ankara University School of Medicine, Ankara, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Leukemia, juvenile myelomonocytic

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Graft-versus-host disease

  • Adrenoleukodystrophy

  • Beta-thalassemia

  • Aplastic anemia

  • Fanconi anemia

  • Thalassemia

  • Mucositis

  • Anemia

Biomarkers

  • Breakpoint Cluster Region

  • Protein Tyrosine Phosphatase, Non-Receptor Type 11

  • Red Blood Cells

Drug/Treatment

  • Cyclosporine eent

  • Methotrexate

  • Allopurinol

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim